Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$8.90
-0.02-0.22%
At close: -
$8.99
0.091.01%
After Hours: Jun 20, 6:24 PM EDT
Comments
Loading...
Greenwich LifeSciences Analyst Ratings and Price Targets | NASDAQ:GLSI | Benzinga
Greenwich LifeSciences Inc has a consensus price target of $39 based on the ratings of 1 analysts. The high is $39 issued by HC Wainwright & Co. on April 21, 2025. The low is $39 issued by HC Wainwright & Co. on April 21, 2025. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on April 21, 2025, February 11, 2025, and August 23, 2024, respectively. With an average price target of $38.33 between HC Wainwright & Co., there's an implied 326.39% upside for Greenwich LifeSciences Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
1calculated from analyst ratings
Analyst Ratings for Greenwich LifeSciences
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/21/2025 | Buy Now | 333.81% | HC Wainwright & Co. | Yi Chen60% | $38 → $39 | Maintains | Buy | Get Alert |
| 02/11/2025 | Buy Now | 322.69% | HC Wainwright & Co. | Yi Chen60% | $38 → $38 | Reiterates | Buy → Buy | Get Alert |
| 08/23/2024 | Buy Now | 322.69% | HC Wainwright & Co. | Yi Chen60% | $36 → $38 | Maintains | Buy | Get Alert |
| 05/22/2024 | Buy Now | 300.44% | HC Wainwright & Co. | Yi Chen60% | $36 → $36 | Reiterates | Buy → Buy | Get Alert |
| 02/28/2024 | Buy Now | 300.44% | HC Wainwright & Co. | Yi Chen60% | $36 → $36 | Reiterates | Buy → Buy | Get Alert |
| 02/20/2024 | Buy Now | 300.44% | HC Wainwright & Co. | Yi Chen60% | $38 → $36 | Maintains | Buy | Get Alert |
| 04/10/2023 | Buy Now | 322.69% | HC Wainwright & Co. | Yi Chen60% | $78 → $38 | Reiterates | → Buy | Get Alert |
FAQ
What is the target price for Greenwich LifeSciences (GLSI) stock?
The latest price target for Greenwich LifeSciences (NASDAQ:GLSI) was reported by HC Wainwright & Co. on April 21, 2025. The analyst firm set a price target for $39.00 expecting GLSI to rise to within 12 months (a possible 333.81% upside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Greenwich LifeSciences (GLSI)?
The latest analyst rating for Greenwich LifeSciences (NASDAQ:GLSI) was provided by HC Wainwright & Co., and Greenwich LifeSciences maintained their buy rating.
When was the last upgrade for Greenwich LifeSciences (GLSI)?
There is no last upgrade for Greenwich LifeSciences
When was the last downgrade for Greenwich LifeSciences (GLSI)?
There is no last downgrade for Greenwich LifeSciences.
When is the next analyst rating going to be posted or updated for Greenwich LifeSciences (GLSI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Greenwich LifeSciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Greenwich LifeSciences was filed on April 21, 2025 so you should expect the next rating to be made available sometime around April 21, 2026.
Is the Analyst Rating Greenwich LifeSciences (GLSI) correct?
While ratings are subjective and will change, the latest Greenwich LifeSciences (GLSI) rating was a maintained with a price target of $38.00 to $39.00. The current price Greenwich LifeSciences (GLSI) is trading at is $8.99, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
